Stauderman Kenneth A.

Chief Scientific OfficerCalciMedica, Inc. (CALC) · full profile →Form 4 · filed Jul 29, 2025
Net Buying
Open-Market Buys
$4K
Open-Market Sells
$4K
Net Open-Market Flow
$310
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 28, 2025Buy(P)1K$3.96$4K13K
Jul 25, 2025Sell(S)1K$3.65$4K0

Transaction Codes

P
Open-market purchase
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-020458) within minutes of acceptance. Every field above traces to the original document. Verify it directly: